Search Results 1161-1170 of 17127 for monoclonal antibody

  1. Z-Endoxifen Hydrochloride in Treating Patients with Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer - Mayo Clinic

    Monoclonal antibodies ≤ 3 weeks; Radiation therapy ≤ 3 weeks; Anti-Her-2 directed therapy ≤ 3 weeks. Prior endoxifen therapy; Prior history of: Stroke ≤ 6 ...

  2. A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) - Mayo Clinic

    Any prior systemic chemotherapy, small molecule inhibitors, immune checkpoint inhibitors, other monoclonal antibodies, antibody-drug conjugates ...

  3. CSF1R And TAM Receptor Inhibition With Q702 - Mayo Clinic

    Participation eligibility · Targeted therapeutics other than monoclonal antibodies (e.g., kinases inhibitors) ≤2 weeks prior to registration. · Monoclonal ...

  4. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

    Prior treatment with anti-CD20 monoclonal antibody or alemtuzumab within 3 months prior to start of therapy. Uncontrolled infectious complications not ...

  5. Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) - Mayo Clinic

    deoxyribonucleic acid antibody seropositivity or anti-citrullinated protein antibodies-positive rheumatoid arthritis, or SSc mimics (eg, scleromyxedema,

  6. MBRT1 - Mayo Clinic

    Treatment with a BRAF inhibitor, monoclonal antibodies targeting VEGF (bevacizumab or ramucirumab) or small molecule inhibitors inhibiting VEGF within the ...

  7. A Phase 3, randomized, open-label, controlled study comparing the efficacy and safety of zanidatamab to trastuzumab, each in combination with physician’s choice chemotherapy, for the treatment of participants with metastatic HER2-positive breast cancer - Mayo Clinic

    Participants positive for hepatitis C antibody ... Has a history of life-threatening hypersensitivity to monoclonal antibodies or to recombinant proteins or ...

  8. 53-Week Study Evaluating The Safety And Efficacy Of Intra-Articular Injections Of TPX-100 With Mild To Severe Tibio-Femoral Osteoarthritis Of The Knee - Mayo Clinic

    Currently taking paclitaxel (mitotic inhibitor), natalizumab (anti-integrin monoclonal antibody), or any other anti-integrin treatment. Routine consumption ...

  9. A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 Positive, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    ... monoclonal antibody, including humanized or chimeric antibodies. Subject has ... For subjects who are negative for HBs Ag, but Hepatitis B core antibody ...

  10. Doctors and departments - Mayo Clinic

    Mayo Clinic researchers discovered an autoantibody, later called aquaporin-4-immunoglobulin G, that is a specific marker for NMO . Testing for this autoantibody ...